DTaP vaccine paediatric Tripedia - sanofi pasteur

Drug Profile

DTaP vaccine paediatric Tripedia - sanofi pasteur

Alternative Names: Diphtheria tetanus-acellular pertussis vaccine paediatric - Sanofi-Aventis; Tripedia

Latest Information Update: 19 Jan 2005

Price : $50

At a glance

  • Originator sanofi pasteur
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Diphtheria; Pertussis; Tetanus

Most Recent Events

  • 19 Jan 2005 Aventis Pasteur is now called sanofi pasteur
  • 27 Aug 2004 Aventis has merged with Sanofi-Synthélabo to form Sanofi-Aventis
  • 10 Aug 1992 Launched for Tetanus in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top